4//SEC Filing
Guyer William 4
Accession 0001193125-25-307282
CIK 0001088856other
Filed
Dec 2, 7:00 PM ET
Accepted
Dec 3, 9:19 PM ET
Size
16.9 KB
Accession
0001193125-25-307282
Insider Transaction Report
Form 4
Guyer William
Chief Development Officer
Transactions
- Award
Common Stock
2025-12-01$79.78/sh+224$17,871→ 224 total - Gift
Common Stock
2025-12-02−787→ 0 total(indirect: By Trust) - Other
Common Stock
2025-12-02+787→ 1,235 total - Exercise/Conversion
Common Stock
2025-12-02$21.65/sh+20,000$433,000→ 21,235 total - Sale
Common Stock
2025-12-02$80.05/sh−19,360$1,549,766→ 1,875 total - Sale
Common Stock
2025-12-02$80.88/sh−640$51,760→ 1,235 total - Exercise/Conversion
Stock option (right to buy)
2025-12-02−20,000→ 270,000 totalExercise: $21.65Exp: 2031-09-01→ Common Stock (20,000 underlying)
Footnotes (8)
- [F1]The Reporting Person purchased shares ("Purchase Plan Shares") of the Issuer's common stock pursuant to a purchase plan ("Purchase Plan") established under the Corcept Therapeutics Incorporated 2024 Incentive Award Plan on December 1, 2025.
- [F2]In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase.
- [F3]Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary.
- [F4]Represents the shares held by The Lake Bainwood Living Trust of which the Reporting Person is a co-trustee.
- [F5]Transfer of shares without consideration to the Reporting Person.
- [F6]This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on November 27, 2024 in effect at the time of this transaction.
- [F7]Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $79.78 to $80.68 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- [F8]Fully exercisable.
Documents
Issuer
CORCEPT THERAPEUTICS INC
CIK 0001088856
Entity typeother
Related Parties
1- filerCIK 0001879013
Filing Metadata
- Form type
- 4
- Filed
- Dec 2, 7:00 PM ET
- Accepted
- Dec 3, 9:19 PM ET
- Size
- 16.9 KB